R. Langer

Pathological primary tumour and lymph node regression following neoadjuvant chemotherapy in resectable oesophagogastric cancer: Pooled analysis of 1619 patients from two randomised trials

Background No definitive largescale data exists evaluating the role of pathologically defined regression changes within lymph nodes (LN) of resected oesophagogastric (OG) adenocarcinoma ...

Naureen Starling , MBBS, MD;

A. Athauda ;

M. Nankivell ;

S. Pritchard ;

R. Langer ;

R. Langley ;

K. Von Loga ;

I. Chau ;

David Cunningham ;

H. Grabsch ;

06/30/2022

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

R. Langer

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products